Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t ... view more

RSS Sort By :
TITLE Price Buy Now More options

In this report, the global Schizophrenia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmen...

$ 2900


DelveInsight’s, “ Cognitive Impairment Associated With Schizophrenia (CIAS) -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Cognitive Impairment Associated With Schizophrenia (CIAS). The key objectiv...

$ 1500


DelveInsight “Schizophrenia - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Schizophrenia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and f...

$ 2750


DelveInsight’s “Schizophrenia - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Schizophrenia - Market Insigh...

$ 5750


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


This report studies the global Schizophrenia Therapeutics market, analyzes and researches the Schizophrenia Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top play...

$ 3300


Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizop...

$ 3500


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2017, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Tri...

$ 2500


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H1 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2017, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


Notes: Sales, means the sales volume of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies sales (consumption) of Schizophrenia Drug in United States market, focuses on the top pla...

$ 3800


Notes: Production, means the output of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in Global market, especially in North America, Europe, China, Japan, So...

$ 2900


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms (such as hallucinations or delusions and disorganized...

$ 10995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. GlobalData has released its pharma report, "Schizophrenia - Current and Future Players". The report is a vital source ...

$ 2995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 4995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 6995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 4995


Schizophrenia is a severe mental disorder that affects an individual’s behaviors, thoughts, and emotions; it is extremely heterogeneous, and no two affected individuals have the same experience (Buckley et al., 2009). The disorder is charact...

$ 3995

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: